Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 |  Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $1.34M 4,823 sh |
| Sep 8, 2026 traded Sep 8, 2026 |
| 11 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $4.96M 17.6K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 11 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $4.17M 15.0K sh | Sep 8, 2026 traded Sep 8, 2026 |
| 10 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $623K 2,210 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 10 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $3.26M 31.5K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 9 | Teal-Guess KellieChief Human Resources Officer |  RXTRackspace Technology, Inc.Open-market sale · 10b5-1 plan | SELL | $105K 33.6K sh | Sep 8, 2026 traded Sep 8, 2026 |
| 9 | Kerr DouglasChief Medical Officer |  DYNDyne Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $91K 3,745 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 9 | Peters John SheldonChief Insurance Officer |  LMNDLemonade, Inc.Open-market sale · 10b5-1 plan | SELL | $47K 859 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 9 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 1,416 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 9 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Open-market sale · 10b5-1 plan | SELL | $336K 60.0K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 6 | Peters John SheldonChief Insurance Officer | LMNDLemonade, Inc. Open-market sale · 10b5-1 plan | SELL | $122K 2,249 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 6 | Friedl-Naderer JohannaChief Commercial Officer | DYNDyne Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,493 185 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 6 | Friedl-Naderer JohannaChief Commercial Officer | DYNDyne Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $22K 900 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 6 | Kerr DouglasChief Medical Officer | DYNDyne Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 1,290 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 5 | Codner Elizabeth MChief Human Resources Officer |  PARPAR TECHNOLOGY CORPOpen-market sale · 10b5-1 plan | SELL | $13K 653 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 4 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $663K 2,428 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 4 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $770K 2,753 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 4 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $467K 1,713 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 4 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $384K 1,387 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 4 | Zatlyn MichelleDirector, PRESIDENT & BOARD CO-CHAIR | NETCloudflare, Inc. Open-market sale · 10b5-1 plan | SELL | $604K 2,202 sh | Sep 8, 2026 traded Sep 8, 2026 |
| 52 | Lacerte Rene A.Director, CEO |  BILLBILL Holdings, Inc.Open-market sale | SELL | $4.90M 100.9K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 50 | Spetzler David BaxleyPresident |  CAICaris Life Sciences, Inc.Open-market sale | SELL | $9.73M 393.1K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 48 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $1.94M 40.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 48 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $1.31M 27.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 46 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $260K 9,852 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 46 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $293K 11.3K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 46 | Spetzler David BaxleyPresident | CAICaris Life Sciences, Inc. Open-market sale | SELL | $2.15M 84.9K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 44 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $3.52M 15.5K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 44 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $1.18M 24.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 43 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $52K 1,990 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 42 | Ware J. AnthonyDirector |  TRAXFirst Tracks Biotherapeutics, Inc.Open-market sale | SELL | $1.76M 39.3K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 41 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $511K 10.6K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 41 | Lacerte Rene A.Director, CEO | BILLBILL Holdings, Inc. Open-market sale | SELL | $565K 11.8K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 40 | Simon JoshDirector, Chief Executive Officer |  FNKOFunko, Inc.Open-market sale | SELL | $786K 136.3K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 40 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $1.87M 8,277 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 40 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $46K 1,738 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 40 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $118K 4,481 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 40 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $133K 5,130 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 39 | Turner Matthew BakerPRES., PATIENT AFFORDABILITY |  PAYSPaysign, Inc.Open-market sale | SELL | $63K 15.1K sh | Sep 4, 2026 traded Feb 3, 2026 |
| 39 | Cunningham Bradley KramerChief Technology Officer | PAYSPaysign, Inc. Open-market sale | SELL | $73K 10.0K sh | Sep 4, 2026 traded May 29, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K